PD-L1, treatment intensity, and outcomes in squamous NSCLC – Authors' reply

The Lancet 2026

View at publisher

Authors: Zhiwei Chen, Shun Lu

DOI: 10.1016/s0140-6736(26)00295-3

Cited by: 1

References: 3

Fields of Study & Subjects

Cancer Immunotherapy and Biomarkers Lung Cancer Treatments and Mutations Head and Neck Cancer Studies

References 3